Compare Shanghai Junshi Biosciences Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 7.93% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -69.06
2
Flat results in Dec 23
3
Risky -
4
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
HKD 5,076 Million ()
NA (Loss Making)
NA
0.00%
-0.12
-9.76%
0.74
Revenue and Profits:
Net Sales:
1,116 Million
(Quarterly Results - Jun 2026)
Net Profit:
3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.23%
0%
19.23%
6 Months
-12.24%
0%
-12.24%
1 Year
-37.19%
0%
-37.19%
2 Years
81.32%
0%
81.32%
3 Years
1.48%
0%
1.48%
4 Years
-21.23%
0%
-21.23%
5 Years
-51.95%
0%
-51.95%
Shanghai Junshi Biosciences Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.31%
EBIT Growth (5y)
7.93%
EBIT to Interest (avg)
-61.12
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.18
Tax Ratio
3.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.65
EV to EBIT
-6.62
EV to EBITDA
-9.35
EV to Capital Employed
0.71
EV to Sales
1.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-10.78%
ROE (Latest)
-13.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
1,116.40
819.60
36.21%
Operating Profit (PBDIT) excl Other Income
41.90
-37.00
213.24%
Interest
31.70
27.10
16.97%
Exceptional Items
45.00
-15.10
398.01%
Consolidate Net Profit
3.00
-49.00
106.12%
Operating Profit Margin (Excl OI)
-43.30%
-153.20%
10.99%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 36.21% vs 7.88% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 106.12% vs 86.67% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,700.20
2,105.90
28.22%
Operating Profit (PBDIT) excl Other Income
-667.30
-1,094.00
39.00%
Interest
81.90
56.10
45.99%
Exceptional Items
16.70
-51.70
132.30%
Consolidate Net Profit
-1,094.70
-1,496.30
26.84%
Operating Profit Margin (Excl OI)
-375.00%
-687.90%
31.29%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 28.22% vs 27.21% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 26.84% vs 46.60% in Dec 2024
About Shanghai Junshi Biosciences Co., Ltd. 
Shanghai Junshi Biosciences Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






